tetano
Editor, Senior Moderator
Front Public Health
. 2021 Nov 23;9:770985.
doi: 10.3389/fpubh.2021.770985. eCollection 2021.
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
Farah Yasmin[SUP] 1 [/SUP], Hala Najeeb[SUP] 1 [/SUP], Abdul Moeed[SUP] 1 [/SUP], Unaiza Naeem[SUP] 1 [/SUP], Muhammad Sohaib Asghar[SUP] 2 [/SUP], Najeeb Ullah Chughtai[SUP] 3 [/SUP], Zohaib Yousaf[SUP] 4 [/SUP], Binyam Tariku Seboka[SUP] 5 [/SUP], Irfan Ullah[SUP] 6 [/SUP], Chung-Ying Lin[SUP] 7 [/SUP], Amir H Pakpour[SUP] 8 [/SUP]
Affiliations
Abstract
Vaccine hesitancy in the US throughout the pandemic has revealed inconsistent results. This systematic review has compared COVID-19 vaccine uptake across US and investigated predictors of vaccine hesitancy and acceptance across different groups. A search of PUBMED database was conducted till 17th July, 2021. Articles that met the inclusion criteria were screened and 65 studies were selected for a quantitative analysis. The overall vaccine acceptance rate ranged from 12 to 91.4%, the willingness of studies using the 10-point scale ranged from 3.58 to 5.12. Increased unwillingness toward COVID-19 vaccine and Black/African Americans were found to be correlated. Sex, race, age, education level, and income status were identified as determining factors of having a low or high COVID-19 vaccine uptake. A change in vaccine acceptance in the US population was observed in two studies, an increase of 10.8 and 7.4%, respectively, between 2020 and 2021. Our results confirm that hesitancy exists in the US population, highest in Black/African Americans, pregnant or breastfeeding women, and low in the male sex. It is imperative for regulatory bodies to acknowledge these statistics and consequently, exert efforts to mitigate the burden of unvaccinated individuals and revise vaccine delivery plans, according to different vulnerable subgroups, across the country.
Keywords: COVID-19 vaccines; United States; intent to vaccinate; severe acute respiratory coronavirus 2 (SARS-CoV-2); vaccine acceptance; vaccine hesitancy.
. 2021 Nov 23;9:770985.
doi: 10.3389/fpubh.2021.770985. eCollection 2021.
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
Farah Yasmin[SUP] 1 [/SUP], Hala Najeeb[SUP] 1 [/SUP], Abdul Moeed[SUP] 1 [/SUP], Unaiza Naeem[SUP] 1 [/SUP], Muhammad Sohaib Asghar[SUP] 2 [/SUP], Najeeb Ullah Chughtai[SUP] 3 [/SUP], Zohaib Yousaf[SUP] 4 [/SUP], Binyam Tariku Seboka[SUP] 5 [/SUP], Irfan Ullah[SUP] 6 [/SUP], Chung-Ying Lin[SUP] 7 [/SUP], Amir H Pakpour[SUP] 8 [/SUP]
Affiliations
- PMID: 34888288
- PMCID: PMC8650625
- DOI: 10.3389/fpubh.2021.770985
Abstract
Vaccine hesitancy in the US throughout the pandemic has revealed inconsistent results. This systematic review has compared COVID-19 vaccine uptake across US and investigated predictors of vaccine hesitancy and acceptance across different groups. A search of PUBMED database was conducted till 17th July, 2021. Articles that met the inclusion criteria were screened and 65 studies were selected for a quantitative analysis. The overall vaccine acceptance rate ranged from 12 to 91.4%, the willingness of studies using the 10-point scale ranged from 3.58 to 5.12. Increased unwillingness toward COVID-19 vaccine and Black/African Americans were found to be correlated. Sex, race, age, education level, and income status were identified as determining factors of having a low or high COVID-19 vaccine uptake. A change in vaccine acceptance in the US population was observed in two studies, an increase of 10.8 and 7.4%, respectively, between 2020 and 2021. Our results confirm that hesitancy exists in the US population, highest in Black/African Americans, pregnant or breastfeeding women, and low in the male sex. It is imperative for regulatory bodies to acknowledge these statistics and consequently, exert efforts to mitigate the burden of unvaccinated individuals and revise vaccine delivery plans, according to different vulnerable subgroups, across the country.
Keywords: COVID-19 vaccines; United States; intent to vaccinate; severe acute respiratory coronavirus 2 (SARS-CoV-2); vaccine acceptance; vaccine hesitancy.